Acquired Hemophilia A in IgG4-Related Disease: Case Report, Immunopathogenic Study, and Review of the Literature.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2020
Historique:
received: 04 05 2020
accepted: 16 11 2020
entrez: 11 1 2021
pubmed: 12 1 2021
medline: 20 5 2021
Statut: epublish

Résumé

We report the observation of a 75-year-old patient referred for cervical lymphadenopathies. A pre-lymphadenectomy blood work revealed an asymptomatic elevation of aPTT with low factor VIII (FVIII) levels and high anti-FVIII antibodies titers, consistent with acquired hemophilia A (AHA). Histological work-up of a cervical lymphadenopathy revealed benign follicular hyperplasia with IgG4

Identifiants

pubmed: 33424828
doi: 10.3389/fimmu.2020.558811
pmc: PMC7793697
doi:

Substances chimiques

Autoantibodies 0
Immunoglobulin G 0
F8 protein, human 839MOZ74GK
Factor VIII 9001-27-8

Types de publication

Case Reports Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

558811

Informations de copyright

Copyright © 2020 Sanges, Jeanpierre, Lopez, Russick, Delignat, Carpentier, Dubois, Dubucquoi, Guerrier, Hachulla, Hatron, Paris, Susen, Launay, Lacroix-Desmazes and Terriou.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Gut. 2016 Aug;65(8):1322-32
pubmed: 26964842
Arthritis Care Res (Hoboken). 2011 Aug;63(8):1209-12
pubmed: 21523922
Int J Hematol. 2018 Sep;108(3):335-338
pubmed: 29582334
Thromb Res. 2001 Dec 15;104(6):381-8
pubmed: 11755947
Intern Med. 2012;51(22):3151-4
pubmed: 23154722
Thromb Haemost. 2002 Aug;88(2):362-4
pubmed: 12195715
Thromb Haemost. 1998 Apr;79(4):872-5
pubmed: 9569207
Exp Ther Med. 2016 Dec;12(6):3988-3992
pubmed: 28105131
Ann Rheum Dis. 2020 Jan;79(1):77-87
pubmed: 31796497
Eur J Haematol. 2015 Dec;95 Suppl 81:36-44
pubmed: 26679396
Blood. 1998 Jul 15;92(2):496-506
pubmed: 9657749
Annu Rev Pathol. 2014;9:315-47
pubmed: 24111912
Blood. 1987 May;69(5):1475-80
pubmed: 2436689
J Med Case Rep. 2012 Feb 14;6:63
pubmed: 22333532

Auteurs

Sébastien Sanges (S)

Univ. Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, France.
Inserm, Lille, France.
CHU Lille, Département de Médecine Interne et Immunologie Clinique, Lille, France.
CHU Lille, Département de Médecine Interne et Immunologie Clinique, Centre de Référence des Maladies Auto-Immunes Systémiques Rares du Nord et Nord-Ouest, Lille, France.
Health Care Provider of the European Reference Network on Rare Connective Tissue and Musculoskeletal Diseases Network (ReCONNET), Lille, France.

Emmanuelle Jeanpierre (E)

CHU Lille, Institut d'Hématologie Transfusion, Lille, France.
INSERM, U1011, Univ. Lille, U1011-EGID, Institut Pasteur de Lille, Lille, France.

Benjamin Lopez (B)

CHU Lille, Institut d'Immunologie, Lille, France.

Jules Russick (J)

Centre de recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Paris, France.

Sandrine Delignat (S)

Centre de recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Paris, France.

Benjamin Carpentier (B)

Service d'Hématologie, Hôpital Saint-Vincent, GHICL, Lille, France.

Romain Dubois (R)

CHU Lille, Institut de Pathologie, Lille, France.

Sylvain Dubucquoi (S)

Univ. Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, France.
Inserm, Lille, France.
CHU Lille, Institut d'Immunologie, Lille, France.

Thomas Guerrier (T)

Univ. Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, France.
Inserm, Lille, France.
CHU Lille, Institut d'Immunologie, Lille, France.

Éric Hachulla (É)

Univ. Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, France.
Inserm, Lille, France.
CHU Lille, Département de Médecine Interne et Immunologie Clinique, Lille, France.
CHU Lille, Département de Médecine Interne et Immunologie Clinique, Centre de Référence des Maladies Auto-Immunes Systémiques Rares du Nord et Nord-Ouest, Lille, France.
Health Care Provider of the European Reference Network on Rare Connective Tissue and Musculoskeletal Diseases Network (ReCONNET), Lille, France.

Pierre-Yves Hatron (PY)

CHU Lille, Département de Médecine Interne et Immunologie Clinique, Lille, France.
CHU Lille, Département de Médecine Interne et Immunologie Clinique, Centre de Référence des Maladies Auto-Immunes Systémiques Rares du Nord et Nord-Ouest, Lille, France.
Health Care Provider of the European Reference Network on Rare Connective Tissue and Musculoskeletal Diseases Network (ReCONNET), Lille, France.

Camille Paris (C)

CHU Lille, Institut d'Hématologie Transfusion, Lille, France.
INSERM, U1011, Univ. Lille, U1011-EGID, Institut Pasteur de Lille, Lille, France.

Sophie Susen (S)

CHU Lille, Institut d'Hématologie Transfusion, Lille, France.
INSERM, U1011, Univ. Lille, U1011-EGID, Institut Pasteur de Lille, Lille, France.

David Launay (D)

Univ. Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, France.
Inserm, Lille, France.
CHU Lille, Département de Médecine Interne et Immunologie Clinique, Lille, France.
CHU Lille, Département de Médecine Interne et Immunologie Clinique, Centre de Référence des Maladies Auto-Immunes Systémiques Rares du Nord et Nord-Ouest, Lille, France.
Health Care Provider of the European Reference Network on Rare Connective Tissue and Musculoskeletal Diseases Network (ReCONNET), Lille, France.

Sébastien Lacroix-Desmazes (S)

Centre de recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Paris, France.

Louis Terriou (L)

CHU Lille, Département de Médecine Interne et Immunologie Clinique, Lille, France.
CHU Lille, Département de Médecine Interne et Immunologie Clinique, Centre de Référence des Maladies Auto-Immunes Systémiques Rares du Nord et Nord-Ouest, Lille, France.
Health Care Provider of the European Reference Network on Rare Connective Tissue and Musculoskeletal Diseases Network (ReCONNET), Lille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH